'Inferiority trial' presentation slideshows

Instructions received from Program C hair A. Gronchi

436 views • 35 slides

Analysis of Cardiovascular Thromboembolic Events With Etoricoxib

Analysis of Cardiovascular Thromboembolic Events With Etoricoxib. Joel Schiffenbauer, M.D. DAAODP, ODE V February 17, 2005. Etoricoxib. NDA indications include: OA, CLBP, RA, AS, acute gout, acute pain, dysmenorrhea Proposed doses: 60 and 90 mg chronically and 120 mg acutely

793 views • 31 slides

Atlantic Cardiovascular Patient Outcomes Research Team

Atlantic Cardiovascular Patient Outcomes Research Team. CPORT- E Trial Randomized trial comparing medical, economic and quality of life outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery. Motivation for Trial. Sustain primary PCI program at no-SOS hospitals

417 views • 31 slides

A Flexible Two Stage Design in Active Control Non-inferiority Trials

383 views • 24 slides

Atlantic Cardiovascular Patient Outcomes Research Team

Atlantic Cardiovascular Patient Outcomes Research Team. CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery. Motivation for Trial. Sustain primary PCI program at no-SOS hospitals Improve access to PCI services

258 views • 18 slides

Resolute all comers trial

Resolute all comers trial. Objective: To compare the efficacy and safety of the new generation ZES stent versus the everolimus eluting stent. Study: Multicenter, single blind, randomized non- inferiority trial.

272 views • 5 slides